A61K 49 - Preparations for testing in vivo

Patents for A61K 49 - Preparations for testing in vivo (35,376)
11/2009
11/11/2009	EP2114454A2 Chemical linkers and cleavable substrates and conjugates thereof
11/11/2009	EP2114422A1 Osteopontin for the prediction and treatment of cardiovascular diseases
11/11/2009	EP2114141A2 Compounds and methods for treatment of alpha-1 antitrypsin deficiency
11/11/2009	EP1490120B1 Embolization
11/11/2009	EP1482795B1 New immunoeffector compounds
11/11/2009	CN101578111A Vaccine for avian influenza and methods of use
11/11/2009	CN101574530A Novel PLGA-PEG-PLGA multipolymer microbubble ultrasound contrast agent and preparation method thereof
11/11/2009	CN101574529A Application of near infrared fluorescent chemical in lymphaden imaging and angiogram
11/11/2009	CN101574350A Application of imatinib mesylate in preparing drugs used for building congenital cataract animal model
11/11/2009	CN101574074A Model for dcf-1 gene knockout mouse, construction method and applications thereof
11/11/2009	CN100558728C Calcitonin gene related peptide receptor antagonists
11/11/2009	CN100558718C Piperazinyl and diazapanyl benzamides and benzthioamides
11/11/2009	CN100558411C Tenascin-C nucleic acid ligands
11/10/2009	US7616985 Method and apparatus for 3-D imaging of internal light sources
11/10/2009	US7615543 Complexes with C-reactive protein (CRP) molecules; rheumatoid arthritis, juvenile chronic (rheumatoid) arthritis, ankylosing spondylitis, psoriatic arthritis, systemic vasculitis, polymyalgia rheumatica, Reiter's disease, Crohn's disease and familial Mediterranean fever
11/10/2009	US7615233 Particulate construct comprising polyhydroxyalkanoate and method for producing it
11/10/2009	US7615208 Administering a radionuclide-labeled bis-aminoethanethiol (BAT) tetradentate targeting ligand conjugate, which is a folate receptor targeting ligand, an agent that mimics glucose, annexin V, colchicine, glutamate pentapeptide, or a tumor hypoxia targeting ligand
11/10/2009	US7615207 Methods for treating irritable bowel syndrome
11/05/2009	WO2009135178A2 Methods for production and use of substance-loaded erythrocytes (s-les) for observation and treatment of microvascular hemodynamics
11/05/2009	WO2009134435A2 Compositions and methods for producing emulsions for nuclear magnetic resonance techniques and other applications
11/05/2009	WO2009133867A1 Liposome containing metal colloid
11/05/2009	WO2009133647A1 Polymerized cyclic nitroxide radical compound, and use thereof
11/05/2009	WO2009133362A2 Agents for detecting and imaging cell death
11/05/2009	WO2009133203A2 In vivo imaging
11/05/2009	WO2009133169A1 Method of determining alanine transaminase (alt) activity by 13c-mr detection using hyperpolarised 13c-pyruvate
11/05/2009	WO2009133071A2 Polyelectrolyte with positive net charge for use as medicament and diagnostic for cancer
11/05/2009	WO2009109588A9 Novel mixed ligand core/shell iron oxide nanoparticles for inflammation imaging
11/05/2009	WO2009069051A3 Non-spherical contrast agents for cest mri based on bulk magnetic susceptibility effect
11/05/2009	WO2006078979A4 Vectors and methods for genetic immunization
11/05/2009	US20090276863 Protein formulations comprising s1-5
11/05/2009	US20090275124 Methods and Compositions Comprising Anti-Idiotypic Antibodies to Anti-MMP-14 Antibodies
11/05/2009	US20090274630 Red blood cell-derived vesicles as a nanoparticle drug delivery system
11/05/2009	US20090274629 Sanitizing Composition and Method of Preparation
11/05/2009	US20090274628 Reconstitutable microsphere compositions useful as ultrasonic contrast agents
11/05/2009	US20090274627 Composition for Regeneration of Periodontal Soft Tissue and Method for Producing the Same
11/05/2009	US20090274626 TARGETING TNF-alpha CONVERTING ENZYME(TACE)- DEPENDENT GROWTH FACTOR SHEDDING IN CANCER THERAPY
11/05/2009	US20090274625 Compositions and Methods for The Treatment of Cancer
11/05/2009	US20090274623 In vivo imaging agents for met receptor tyrosine kinase
11/05/2009	US20090274622 Necrosis avid tracer agent
11/05/2009	US20090274621 Use of pyrene to carry non-peptide agents across the blood brain barrier
11/05/2009	US20090274619 Tumor vasculature markers and methods of use therof
11/05/2009	CA2723171A1 Compositions and methods for producing emulsions for nuclear magnetic resonance techniques and other applications
11/05/2009	CA2723118A1 Polymerized cyclic nitroxide radical compound and use thereof
11/05/2009	CA2722914A1 Agents for detecting and imaging cell death
11/04/2009	EP2113257A1 Polyelectrolyte with positive net charge for use as medicament and diagnostic for cancer
11/04/2009	EP1729823B1 Conjugates of angiotensin peptidic analogues and chelating agents for diagnosis and therapy
11/04/2009	EP1204430B1 Conjugates and methods for the production thereof, and their use for transporting molecules via biological membranes
11/03/2009	US7611857 Identifying a modulator of IL-17 receptor-like polypeptide activity; drug screening; treating inflammation
11/03/2009	US7611720 Tuberculosis vaccines including recombinant BCG strains expressing alanine dehydrogenase, serine dehydratase and/or glutamine synthetase
11/03/2009	US7611693 Mechanism-based targeted pancreatic beta cell imaging and therapy
11/03/2009	US7611692 bombesin, derivatives and/or analogues capable of complexing metal ions, radionuclides or optical labels, for use in radiotherapy
11/03/2009	CA2155813C Agents and a method of chromosome preparation using protein phosphatase inhibitors induced premature chromosome condensation
10/2009
10/29/2009	WO2009132251A2 Methods and compositions comprising anti-idiotypic antibodies to anti-mmp-14 antibodies
10/29/2009	WO2009130893A1 Method of detecting bladder cancer
10/29/2009	WO2009129649A1 Biocompatible polymer and magnetic nanoparticle with biocompatibility
10/29/2009	WO2009129619A1 Aptamers for detection and imaging of apoptosis
10/29/2009	WO2009129578A1 Methods for radiolabelling synthetic polymers
10/29/2009	WO2009129577A1 Methods for radiolabelling macromolecules
10/29/2009	WO2009092062A3 Fluorescent imaging agents
10/29/2009	WO2009008734A3 Contrast agents
10/29/2009	US20090271879 Analogues of (-)-picropodophyllin, synthesis and uses thereof
10/29/2009	US20090270329 Methods of administering porcine b-domainless fviii
10/29/2009	US20090269285 Diagnostic And Therapeutic Epitope, And Transgenic Plant
10/29/2009	US20090269284 Contrast agents
10/29/2009	US20090269283 Method and product for locating an internal bleeding site
10/29/2009	US20090269282 Methods for treating, preventing and diagnosing procine ttv infection
10/29/2009	US20090269281 Calcium/Calmodulin-Dependent Protein Kinase Kinase as a Control Point for Cardiac Hypertrophy
10/29/2009	US20090269280 Method for activation of transient receptor potential cation channel, subfamily a, member 1 using acetaldehyde
10/29/2009	US20090269279 Toxicology and Cellular Effect of Manufactured Nanomaterials
10/29/2009	US20090269277 Multivalent Immunoglobulin-Based Bioactive Assemblies
10/29/2009	DE102008001437A1 Oberflächenmodifizierte, superparamagnetische oxidische Partikel The surface-modified superparamagnetic oxide particles
10/29/2009	CA2721836A1 Methods for radiolabelling macromolecules
10/29/2009	CA2721835A1 Methods for radiolabelling synthetic polymers
10/28/2009	EP2111237A2 Fibrin-binding peptides and conjugates thereof
10/28/2009	EP2111236A2 Novel cascade polymer complexes, method for their production and pharmaceutical agents containing the same
10/28/2009	EP2111235A1 A method for diagnosing disease using adenovirus harboring trans-splicing ribozyme by molecular imaging
10/28/2009	EP1624936B1 Cns chloride modulation and uses thereof
10/28/2009	EP1503800B1 Treatment and prevention of tissue damage associated with increased c-reactive protein production
10/28/2009	CN101568352A Methods and compositions for improved f-18 labeling of proteins, peptides and other molecules
10/28/2009	CN101565453A Nitrone compound capable of capturing free radicals, preparation method thereof and use thereof
10/28/2009	CN101564540A Gd-DTPA-Polylysine-McAb junctional complex, preparation method and application thereof
10/28/2009	CN100553684C Method for preparing MRI visible, liver target and degradable nano-gene vector
10/27/2009	US7610074 Multi-functional plasmon-resonant contrast agents for optical coherence tomography
10/27/2009	US7608278 Less painful immunogenic composition of a hydrophobic protein; solubilizing hydrophobic protein with a zwitterionic detergent to make a composition that is then altered; meningitis or gonorrhea
10/27/2009	US7608277 Tuberculosis nucleic acids, polypeptides and immunogenic compositions
10/27/2009	US7608249 Magnetic resonance imaging of substrate molecule different from water; shortening relaxation times; in vivo mapping citrate; tumors
10/27/2009	US7608247 vaccinating a mammal to produce a polyclonal antibody against Escherichia coli infection in central nervous system and/or peripheral blood circulation, comprises administering to the mammal an effective amount of an outer membrane protein A (OmpA) of Escherichia coli
10/27/2009	US7608246 combination of apolipoprotein E and an antigenic lipid administered to a subject for the purpose of inducing an immune response against the lipid and in immunization protocols
10/27/2009	US7608245 Transmission and, or amplification of signal ; oral or enteric administering; dissolving; absorption by small inteestines; peptide yy; obesity therapy
10/27/2009	US7608244 benz[e]indole derivatives that absorb and fluoresce in the visible region of light, particularly useful for optical diagnosis of renal and cardiac diseases and for estimation of blood volume in vivo; low molecular weight compounds; non-immunogenic
10/27/2009	CA2584638C Medical device for generating transient bubbles
10/27/2009	CA2394539C Near infrared fluorescent contrast agent and fluorescence imaging
10/27/2009	CA2162366C Conjugation-stabilized polypeptide compositions
10/22/2009	WO2009129537A2 Magnetic microstructures for magnetic resonance imaging
10/22/2009	WO2009129482A1 Methods and compositions for molecular imaging
10/22/2009	WO2009129220A2 Plectin-1 targeted agents for detection and treatment of pancreatic ductal adenocarcinoma
10/22/2009	WO2009081169A8 Biodegradable contrast agents
10/22/2009	US20090264365 Conformationally constrained parathyroid hormone (pth) analogs
10/22/2009	US20090263868 Nucleotide Compositions Comprising Photocleavable Markers And Methods Of Preparation Thereof
10/22/2009	US20090263442 implanting post-procedure cavity implant into cavity through incision and through access path, and closing incision, wherein implanted post-procedure cavity implant swells within biological fluid environment of cavity to a post-implantation state and no longer fits through the access path

1 ... 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 ... 354